Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Stephen Waldo to Treatment Outcome

This is a "connection" page, showing publications Stephen Waldo has written about Treatment Outcome.

 
Connection Strength
  
 
 
2.848
  
  1. Kovach CP, Lipinski J, Mesenbring EC, Boulos P, Pribish A, Sola M, Glorioso TJ, Fearon WF, Yeh RW, Waldo SW. Characteristics and Outcomes of PCI Among Patients Ineligible for Surgical Revascularization in the Veterans Affairs Healthcare System. Circ Cardiovasc Interv. 2025 Mar; 18(3):e014899.
    View in: PubMed
    Score: 0.086
  2. Butala NM, Hebbe A, Shah B, Smilowitz NR, Aijaz B, Uzendu A, Boulos P, Waldo SW. Outcomes After Noncardiac Surgery Performed Within 2?Years of Percutaneous Coronary Intervention. J Am Heart Assoc. 2025 Mar 18; 14(6):e038807.
    View in: PubMed
    Score: 0.086
  3. Aijaz B, Glorioso TJ, Butala N, Waldo SW. Temporal trends and hospital variation in the use of P2Y12 inhibitors among patients undergoing percutaneous coronary intervention: Insights from the VA CART program. Catheter Cardiovasc Interv. 2023 09; 102(3):503-504.
    View in: PubMed
    Score: 0.077
  4. Kovach CP, Valle JA, Waldo SW. Reply: Pitfalls of Simplifying the Original SYNTAX Score: A Temptation That Should Be?Resisted. JACC Cardiovasc Interv. 2023 04 24; 16(8):1004.
    View in: PubMed
    Score: 0.075
  5. Kovach CP, Waldo SW. Reply: Egg or Chicken First?: Is it Really Useful to Achieve Complete Revascularization? JACC Cardiovasc Interv. 2023 03 13; 16(5):620-621.
    View in: PubMed
    Score: 0.075
  6. Kovach CP, Hebbe A, Glorioso TJ, Barrett C, Bar?n AE, Mavromatis K, Valle JA, Waldo SW. Association of Residual Ischemic Disease With Clinical Outcomes After Percutaneous Coronary Intervention. JACC Cardiovasc Interv. 2022 12 26; 15(24):2475-2486.
    View in: PubMed
    Score: 0.074
  7. Kovach C, Banerjee S, Waldo S. Radial Artery Access for Acute Coronary Syndromes: a Review of Current Evidence. Curr Cardiol Rep. 2022 04; 24(4):383-392.
    View in: PubMed
    Score: 0.070
  8. Waldo SW, Glorioso TJ, Bar?n AE, Doll JA, Plomondon ME, Ho PM. Transitions of Care Among Patients Undergoing Percutaneous Coronary Intervention for Stable Angina: Insights From the Veterans Affairs Clinical Assessment Reporting and Tracking Program. J Am Heart Assoc. 2022 02 15; 11(4):e024598.
    View in: PubMed
    Score: 0.069
  9. Doll JA, O'Donnell CI, Plomondon ME, Waldo SW. Contemporary Clinical and Coronary Anatomic Risk Model for 30-Day Mortality After Percutaneous Coronary Intervention. Circ Cardiovasc Interv. 2021 12; 14(12):e010863.
    View in: PubMed
    Score: 0.069
  10. Kovach CP, Hebbe A, Bar?n AE, Strobel A, Plomondon ME, Valle JA, Waldo SW. Clinical Characteristics and Outcomes Among Patients Undergoing High-Risk Percutaneous Coronary Interventions by Single or Multiple Operators: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. J Am Heart Assoc. 2021 12 07; 10(23):e022131.
    View in: PubMed
    Score: 0.068
  11. Kovach CP, O'Donnell CI, Swat S, Doll JA, Plomondon ME, Schofield R, Valle JA, Waldo SW. Impact of Operator Volumes and Experience on Outcomes After Percutaneous Coronary Intervention: Insights From the Veterans Affairs Clinical Assessment, Reporting and Tracking (CART) Program. Cardiovasc Revasc Med. 2022 07; 40:64-68.
    View in: PubMed
    Score: 0.068
  12. Waldo SW, Hebbe A, Grunwald GK, Doll JA, Schofield R. Clinical and Anatomic Complexity of Patients Undergoing Coronary Intervention With and Without On-Site Surgical Capabilities: Insights From the Veterans Affairs Clinical Assessment, Reporting and Tracking (CART) Program. Circ Cardiovasc Interv. 2021 01; 14(1):e009697.
    View in: PubMed
    Score: 0.064
  13. Waldo SW, Glorioso TJ, Bar?n AE, Plomondon ME, Valle JA, Schofield R, Ho PM. Outcomes Among Patients Undergoing Elective Percutaneous Coronary Intervention at Veterans Affairs and Community Care Hospitals. J Am Coll Cardiol. 2020 09 01; 76(9):1112-1116.
    View in: PubMed
    Score: 0.063
  14. Doll JA, O'Donnell CI, Plomondon ME, Waldo SW. Development and Implementation of an In-Hospital Bleeding Risk Model for Percutaneous Coronary Intervention. Cardiovasc Revasc Med. 2021 07; 28:20-24.
    View in: PubMed
    Score: 0.062
  15. Barrett C, Warsavage T, Kovach C, McGuinn E, Plomondon ME, Armstrong EJ, Waldo SW. Comparison of rotational and orbital atherectomy for the treatment of calcific coronary lesions: Insights from the VA clinical assessment reporting and tracking (CART) program. Catheter Cardiovasc Interv. 2021 02 01; 97(2):E219-E226.
    View in: PubMed
    Score: 0.062
  16. Prouse A, Gunzburger E, Yang F, Morrison J, Valle JA, Armstrong EJ, Waldo SW. Contemporary Use and Outcomes of Arterial Closure Devices After Percutaneous Coronary Intervention: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. J Am Heart Assoc. 2020 02 18; 9(4):e015223.
    View in: PubMed
    Score: 0.061
  17. Valle JA, Glorioso TJ, Bricker R, Bar?n AE, Armstrong EJ, Bhatt DL, Rao SV, Plomondon ME, Serruys PW, Keppetein AP, Sabik JF, Dressler O, Stone GW, Waldo SW. Association of Coronary Anatomical Complexity With Clinical Outcomes After Percutaneous or Surgical Revascularization in the Veterans Affairs Clinical Assessment Reporting and Tracking Program. JAMA Cardiol. 2019 08 01; 4(8):727-735.
    View in: PubMed
    Score: 0.058
  18. Valle JA, Glorioso TJ, Schuetze KB, Grunwald GK, Armstrong EJ, Waldo SW. Contemporary Use of Embolic Protection Devices During Saphenous Vein Graft Intervention. Circ Cardiovasc Interv. 2019 05; 12(5):e007636.
    View in: PubMed
    Score: 0.057
  19. Bricker RS, Valle JA, Plomondon ME, Armstrong EJ, Waldo SW. Causes of Mortality After Percutaneous Coronary Intervention. Circ Cardiovasc Qual Outcomes. 2019 05; 12(5):e005355.
    View in: PubMed
    Score: 0.057
  20. Bagai J, Hess E, Penny WF, Plomondon ME, Waldo SW. Outcomes of Transradial PCI compared to Transfemoral PCI in veterans with anemia: Insight from the VA Clinical Assessment, Reporting and Tracking (CART) program. Cardiovasc Revasc Med. 2019 Nov; 20(11):990-996.
    View in: PubMed
    Score: 0.056
  21. Prouse AF, Langner P, Plomondon ME, Ho PM, Valle JA, Bar?n AE, Armstrong EJ, Waldo SW. Temporal trends in the management and clinical outcomes of lower extremity arterial thromboembolism within a national Veteran population. Vasc Med. 2019 02; 24(1):41-49.
    View in: PubMed
    Score: 0.055
  22. Waldo SW, Gokhale M, O'Donnell CI, Plomondon ME, Valle JA, Armstrong EJ, Schofield R, Fihn SD, Maddox TM. Temporal Trends in Coronary?Angiography and Percutaneous?Coronary?Intervention: Insights From the VA Clinical Assessment, Reporting, and Tracking Program. JACC Cardiovasc Interv. 2018 05 14; 11(9):879-888.
    View in: PubMed
    Score: 0.054
  23. Valle JA, Kaltenbach LA, Bradley SM, Yeh RW, Rao SV, Gurm HS, Armstrong EJ, Messenger JC, Waldo SW. Variation in the Adoption of Transradial?Access for ST-Segment Elevation Myocardial Infarction: Insights From the NCDR CathPCI Registry. JACC Cardiovasc Interv. 2017 11 27; 10(22):2242-2254.
    View in: PubMed
    Score: 0.052
  24. Armstrong EJ, Stanislawski MA, Kokkinidis DG, Plomondon ME, Bar?n AE, Giri J, Shunk KA, Banerjee S, Maddox TM, Waldo SW. Coronary atherectomy is associated with improved procedural and clinical outcomes among patients with calcified coronary lesions: Insights from the VA CART program. Catheter Cardiovasc Interv. 2018 05 01; 91(6):1009-1017.
    View in: PubMed
    Score: 0.051
  25. Waldo SW, O'Donnell CI, Prouse A, Plomondon ME, Rao SV, Maddox TM, Ho PM, Armstrong EJ. Incidence, procedural management, and clinical outcomes of coronary in-stent restenosis: Insights from the National VA CART Program. Catheter Cardiovasc Interv. 2018 02 15; 91(3):425-433.
    View in: PubMed
    Score: 0.050
  26. Armstrong EJ, Waldo SW. Commentary: Next-Generation Drug-Coated Balloons: A New Era for Endovascular Therapy of the Femoropopliteal Arteries? J Endovasc Ther. 2017 08; 24(4):468-470.
    View in: PubMed
    Score: 0.050
  27. Foley TR, Armstrong EJ, Waldo SW. Contemporary evaluation and management of lower extremity peripheral artery disease. Heart. 2016 09 15; 102(18):1436-41.
    View in: PubMed
    Score: 0.047
  28. Waldo SW, Abtahian F, Kennedy KF, Scirica BM, Mahmood S, Yeh RW. Incidence and predictors of incomplete revascularization in a contemporary cohort. Coron Artery Dis. 2016 May; 27(3):191-8.
    View in: PubMed
    Score: 0.047
  29. Armstrong EJ, Bishu K, Waldo SW. Endovascular Treatment of Infrapopliteal Peripheral Artery Disease. Curr Cardiol Rep. 2016 Apr; 18(4):34.
    View in: PubMed
    Score: 0.046
  30. Waldo SW, Chang L, Strom JB, O'Brien C, Pomerantsev E, Yeh RW. Predicting the Presence of an Acute Coronary Lesion Among Patients Resuscitated From Cardiac Arrest. Circ Cardiovasc Interv. 2015 Oct; 8(10).
    View in: PubMed
    Score: 0.045
  31. Waldo SW, McCabe JM, O'Brien C, Kennedy KF, Joynt KE, Yeh RW. Association between public reporting of outcomes with procedural management and mortality for patients with acute myocardial infarction. J Am Coll Cardiol. 2015 Mar 24; 65(11):1119-26.
    View in: PubMed
    Score: 0.043
  32. Waldo SW, Brenner DA, Li S, Alexander K, Ganz P. Reperfusion times and in-hospital outcomes among patients with an isolated posterior myocardial infarction: insights from the National Cardiovascular Data Registry (NCDR). Am Heart J. 2014 Mar; 167(3):350-4.
    View in: PubMed
    Score: 0.039
  33. Waldo SW, Armstrong EJ, Yeo KK, Patel M, Reeves R, Macgregor JS, Low RI, Mahmud E, Rogers JH, Shunk K. Procedural success and long-term outcomes of aspiration thrombectomy for the treatment of stent thrombosis. Catheter Cardiovasc Interv. 2013 Dec 01; 82(7):1048-53.
    View in: PubMed
    Score: 0.038
  34. Waldo SW, Armstrong EJ, Kulkarni A, Hoffmayer K, Kinlay S, Hsue P, Ganz P, McCabe JM. Comparison of clinical characteristics and outcomes of cardiac arrest survivors having versus not having coronary angiography. Am J Cardiol. 2013 May 01; 111(9):1253-8.
    View in: PubMed
    Score: 0.037
  35. Waldo SW, Armstrong EJ, Yeo KK, Mahmud E, Patel M, Reeves R, MacGregor JS, Low RI, Rogers JH, Shunk KA. Comparison of procedural success and long-term outcomes of stent thrombosis in coronary bypass grafts versus native coronary arteries. Am J Cardiol. 2013 Mar 01; 111(5):689-94.
    View in: PubMed
    Score: 0.037
  36. Stein EJ, Mesenbring E, Smith T, Hebbe A, Salahuddin T, Waldo SW, Dyal MD, Doll JA. Intravascular Imaging as a Performance Measure for Percutaneous Coronary Intervention. Circ Cardiovasc Interv. 2025 Feb; 18(2):e014528.
    View in: PubMed
    Score: 0.021
  37. Doll JA, Hebbe AL, Simons CE, Stein EJ, Eisenbarth S, Waldo SW, Rao SV, Au DH. Evaluation of Peer Review of Percutaneous Coronary Intervention Operator Performance. Circ Cardiovasc Qual Outcomes. 2025 Jan; 18(1):e011159.
    View in: PubMed
    Score: 0.021
  38. Kovach CP, Leonard J, Messenger JC, Waldo SW, Perman SM. Impact of Time to Initiation of Targeted Temperature Management Among Patients with Out-of-Hospital Cardiac Arrest Undergoing Percutaneous Coronary Intervention. Ther Hypothermia Temp Manag. 2025 Jun; 15(2):74-81.
    View in: PubMed
    Score: 0.021
  39. Gonzalez PE, Hebbe A, Hussain Y, Khera R, Banerjee S, Plomondon ME, Waldo SW, Pfau SE, Curtis JP, Shah SM. Real-World Experience and Outcomes With Percutaneous Coronary Intervention for Protected Versus Unprotected Left Main Coronary Artery Disease: Insights from the Veteran Affairs Clinical Assessment Reporting and Tracking Program. Am J Cardiol. 2024 07 01; 222:39-50.
    View in: PubMed
    Score: 0.020
  40. Parikh RV, Hebbe A, Bar?n AE, Grunwald GK, Plomondon ME, Gordin J, Yeh RW, Jneid H, Swaminathan RV, Waldo SW, Monto A, Secemsky E, Hsue PY. Clinical Characteristics and Outcomes Among People Living With HIV Undergoing Percutaneous Coronary Intervention: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. J Am Heart Assoc. 2023 02 21; 12(4):e028082.
    View in: PubMed
    Score: 0.019
  41. Swat SA, Hebbe A, Plomondon ME, Park KE, Bricker RS, Waldo SW, Valle JA. Contemporary Management Before Chronic Total Occlusion Percutaneous Coronary Interventions: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. Circ Cardiovasc Qual Outcomes. 2023 03; 16(3):e008949.
    View in: PubMed
    Score: 0.019
  42. Grines CL, Box LC, Mamas MA, Abbott JD, Blankenship JC, Carr JG, Curzen N, Kent WDT, Khatib Y, Matteau A, Rymer JA, Schreiber TL, Velagapudi P, Vidovich MI, Waldo SW, Seto AH. SCAI Expert Consensus Statement on Percutaneous Coronary Intervention Without On-Site Surgical Backup. JACC Cardiovasc Interv. 2023 04 10; 16(7):847-860.
    View in: PubMed
    Score: 0.019
  43. Chambers JW, Martinsen BJ, Sturm RC, Mandair D, Valle JA, Waldo SW, Guzzetta F, Armstrong EJ. Orbital atherectomy of calcified coronary ostial lesions. Catheter Cardiovasc Interv. 2022 10; 100(4):553-559.
    View in: PubMed
    Score: 0.018
  44. Jovin IS, Warsavage TJ, Plomondon ME, Grunwald GK, Waldo SW, Rao SV, Brilakis ES, Azzalini L. Iso-osmolar versus low-osmolar contrast media and outcomes after percutaneous coronary intervention: Insights from the VA CART Program. Catheter Cardiovasc Interv. 2022 07; 100(1):85-93.
    View in: PubMed
    Score: 0.018
  45. Doll JA, Beaver K, Naranjo D, Waldo SW, Maynard C, Helfrich CD, Rao SV. Trends in Arterial Access Site Selection and Bleeding Outcomes Following Coronary Procedures, 2011-2018. Circ Cardiovasc Qual Outcomes. 2022 05; 15(5):e008359.
    View in: PubMed
    Score: 0.017
  46. Vallurupalli S, Hess E, Plomondon ME, Park K, Waldo SW, Agarwal S, Uretsky BF. Impact of severity of baseline thrombocytopenia on outcomes after percutaneous coronary interventions: Analysis from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (VA CART) Program. Catheter Cardiovasc Interv. 2022 04; 99(5):1491-1497.
    View in: PubMed
    Score: 0.017
  47. Doll JA, Nelson AJ, Kaltenbach LA, Wojdyla D, Waldo SW, Rao SV, Wang TY. Percutaneous Coronary Intervention Operator Profiles and Associations With In-Hospital Mortality. Circ Cardiovasc Interv. 2022 01; 15(1):e010909.
    View in: PubMed
    Score: 0.017
  48. Beaver K, Naranjo D, Doll J, Maynard C, Taylor L, Plomondon M, Waldo S, Helfrich CD, Rao SV. Design and baseline results of a coaching intervention for implementation of trans-radial access in percutaneous coronary intervention. Contemp Clin Trials. 2021 12; 111:106606.
    View in: PubMed
    Score: 0.017
  49. Brophy TJ, Warsavage TJ, Hebbe AL, Plomondon ME, Waldo SW, Rao SV, DeVore AD, Gutierrez JA, Swaminathan RV. Percutaneous coronary intervention in patients with stable coronary artery disease and left ventricular systolic dysfunction: insights from the VA CART program. Am Heart J. 2021 05; 235:149-157.
    View in: PubMed
    Score: 0.016
  50. Sturm R, Armstrong EJ, Benhuri B, Okamoto N, Vengrenyuk Y, Shlofmitz E, Revtyak GE, Martinsen BJ, Igyarto Z, Valle JA, Waldo SW, Aksut B, Bell S, Gardner R, Lee M, Zakir R, Shroff A, Don C, Shlofmitz R, Chambers JW, Kini A, Sharma S. Orbital Atherectomy for Treatment of Severely Calcified Coronary Artery Bifurcation Lesions: A Multicenter Analysis. Cardiovasc Revasc Med. 2021 05; 26:34-38.
    View in: PubMed
    Score: 0.016
  51. Kokkinidis DG, Jawaid O, Cantu D, Martinsen BJ, Igyarto Z, Valle JA, Waldo SW, Armstrong EJ. Two-Year Outcomes of Orbital Atherectomy Combined With Drug-Coated Balloon Angioplasty for Treatment of Heavily Calcified Femoropopliteal Lesions. J Endovasc Ther. 2020 Jun; 27(3):492-501.
    View in: PubMed
    Score: 0.015
  52. Parikh RV, Liu G, Plomondon ME, Sehested TSG, Hlatky MA, Waldo SW, Fearon WF. Utilization and Outcomes of Measuring Fractional Flow Reserve in Patients With Stable Ischemic Heart Disease. J Am Coll Cardiol. 2020 02 04; 75(4):409-419.
    View in: PubMed
    Score: 0.015
  53. Kokkinidis DG, Strobel A, Jawaid O, Haider MN, Alvandi B, Singh GD, Laird JR, Waldo SW, Armstrong EJ. Development and validation of a predictive score for anterograde crossing of infrapopliteal chronic total occlusions: (The Infrapop-CTO Score). Catheter Cardiovasc Interv. 2020 03 01; 95(4):748-755.
    View in: PubMed
    Score: 0.015
  54. Kokkinidis DG, Behan S, Jawaid O, Hossain P, Giannopoulos S, Singh GD, Laird JR, Valle JA, Waldo SW, Armstrong EJ. Laser atherectomy and drug-coated balloons for the treatment of femoropopliteal in-stent restenosis: 2-Year outcomes. Catheter Cardiovasc Interv. 2020 02 15; 95(3):439-446.
    View in: PubMed
    Score: 0.015
  55. Cantu D, Jawaid O, Kokkinidis D, Giannopoulos S, Valle JA, Waldo SW, Singh GD, Armstrong EJ. Outcomes of Drug-Coated Balloon Angioplasty vs. Conventional Balloon Angioplasty for Endovascular Treatment of Common Femoral Artery Atherosclerotic Disease. Cardiovasc Revasc Med. 2020 07; 21(7):867-874.
    View in: PubMed
    Score: 0.015
  56. Xie JX, Gunzburger EC, Kaun L, Plomondon ME, Bar?n AE, Waldo SW, Virani SS, Maddox TM, Mavromatis K. Medical Therapy Utilization and Long-Term Outcomes Following Percutaneous Coronary Intervention: Five-Year Results From the Veterans Affairs Clinical Assessment, Reporting, and Tracking System Program. Circ Cardiovasc Qual Outcomes. 2019 11; 12(11):e005455.
    View in: PubMed
    Score: 0.015
  57. Giannopoulos S, Kokkinidis DG, Jawaid O, Behan S, Hossain P, Alvandi B, Foley TR, Singh GD, Waldo SW, Armstrong EJ. Turbo-Power? Laser Atherectomy Combined with Drug-coated Balloon Angioplasty is Associated with Improved One-Year Outcomes for the Treatment of Tosaka II and III Femoropopliteal In-stent Restenosis. Cardiovasc Revasc Med. 2020 06; 21(6):771-778.
    View in: PubMed
    Score: 0.015
  58. Hall PS, O'Donnell CI, Mathew V, Garcia S, Bavry AA, Banerjee S, Jneid H, Denktas AE, Giacomini JC, Grossman PM, Aggarwal K, Zimmet JM, Tseng EE, Gozdecki L, Burke L, Bertog SC, Buchbinder M, Plomondon ME, Waldo SW, Shunk KA. Outcomes of Veterans Undergoing TAVR Within Veterans Affairs Medical Centers: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. JACC Cardiovasc Interv. 2019 11 11; 12(21):2186-2194.
    View in: PubMed
    Score: 0.015
  59. Sturm R, Martinsen BJ, Valle JA, Waldo SW, Behrens AN, Armstrong EJ. Orbital Atherectomy for Treatment of Complex Severely Calcified Coronary Artery Lesions: Insights from a Veterans Affairs Cohort. Cardiovasc Revasc Med. 2020 Mar; 21(3):330-333.
    View in: PubMed
    Score: 0.014
  60. Kokkinidis DG, Foley TR, Cotter R, Hossain P, Alvandi B, Jawaid O, Haider MN, Singh GD, Waldo SW, Laird JR, Armstrong EJ. Acute and Midterm Outcomes of Antegrade vs Retrograde Crossing Strategies for Endovascular Treatment of Iliac Artery Chronic Total Occlusions. J Endovasc Ther. 2019 06; 26(3):342-349.
    View in: PubMed
    Score: 0.014
  61. Nathan AS, Shah RM, Khatana SA, Dayoub E, Chatterjee P, Desai ND, Waldo SW, Yeh RW, Groeneveld PW, Giri J. Effect of Public Reporting on the Utilization of Coronary Angiography After Out-of-Hospital Cardiac Arrest. Circ Cardiovasc Interv. 2019 04; 12(4):e007564.
    View in: PubMed
    Score: 0.014
  62. Valle JA, Tamez H, Abbott JD, Moussa ID, Messenger JC, Waldo SW, Kennedy KF, Masoudi FA, Yeh RW. Contemporary Use and Trends in Unprotected Left Main Coronary Artery Percutaneous Coronary Intervention in the United States: An Analysis of the National Cardiovascular Data Registry Research to Practice Initiative. JAMA Cardiol. 2019 02 01; 4(2):100-109.
    View in: PubMed
    Score: 0.014
  63. Hu PT, Jones WS, Glorioso TJ, Bar?n AE, Grunwald GK, Waldo SW, Maddox TM, Vidovich M, Banerjee S, Rao SV. Predictors and Outcomes of Staged?Versus One-Time Multivessel?Revascularization in Multivessel?Coronary?Artery Disease: Insights From the VA CART Program. JACC Cardiovasc Interv. 2018 11 26; 11(22):2265-2273.
    View in: PubMed
    Score: 0.014
  64. Cotter R, Kokkinidis DG, Choy HH, Singh GD, Rogers RK, Waldo SW, Laird JR, Armstrong EJ. Long-term outcomes of carotid artery stenting in patients with a contralateral carotid artery occlusion. Catheter Cardiovasc Interv. 2019 01 01; 93(1):E49-E55.
    View in: PubMed
    Score: 0.014
  65. Valle JA, Glorioso TJ, Maddox TM, Armstrong EJ, Waldo SW, Bradley SM, Ho PM. Impact of Patient Distance From Percutaneous Coronary Intervention Centers on Longitudinal Outcomes. Circ Cardiovasc Qual Outcomes. 2018 09; 11(9):e004623.
    View in: PubMed
    Score: 0.014
  66. Smolderen KG, Plomondon ME, Armstrong EJ, Hess E, Waldo S, Tsai TT, Maddox TM. Depression and long-term prognostic outcomes following peripheral endovascular interventions in the VA Healthcare System. Vasc Med. 2018 10; 23(5):454-460.
    View in: PubMed
    Score: 0.013
  67. Kokkinidis DG, Alvandi B, Hossain P, Foley TR, Kielhorn CE, Singh GD, Waldo SW, Laird JR, Armstrong EJ. Midterm Outcomes After Endovascular Intervention for Occluded vs Stenosed External Iliac Arteries. J Endovasc Ther. 2018 Apr; 25(2):183-191.
    View in: PubMed
    Score: 0.013
  68. Kokkinidis DG, Alvandi B, Cotter R, Hossain P, Foley TR, Singh GD, Waldo SW, Laird JR, Armstrong EJ. Long-term outcomes after re-entry device use for recanalization of common iliac artery chronic total occlusions. Catheter Cardiovasc Interv. 2018 09 01; 92(3):526-532.
    View in: PubMed
    Score: 0.013
  69. Kokkinidis DG, Hossain P, Jawaid O, Alvandi B, Foley TR, Singh GD, Waldo SW, Laird JR, Armstrong EJ. Laser Atherectomy Combined With Drug-Coated Balloon Angioplasty Is Associated With Improved 1-Year Outcomes for Treatment of Femoropopliteal In-Stent Restenosis. J Endovasc Ther. 2018 Feb; 25(1):81-88.
    View in: PubMed
    Score: 0.013
  70. Yap J, Singh GD, Kim JS, Soni K, Chua K, Neo A, Koh CH, Armstrong EJ, Waldo SW, Shunk KA, Low RI, Hong MK, Jang Y, Yeo KK. Outcomes of primary percutaneous coronary intervention in acute myocardial infarction due to unprotected left main thrombosis: The Asia-Pacific Left Main ST-Elevation Registry (ASTER). J Interv Cardiol. 2018 Apr; 31(2):129-135.
    View in: PubMed
    Score: 0.013
  71. Kokkinidis DG, Prouse AF, Avner SJ, Lee JM, Waldo SW, Armstrong EJ. Second-generation drug-eluting stents versus drug-coated balloons for the treatment of coronary in-stent restenosis: A systematic review and meta-analysis. Catheter Cardiovasc Interv. 2018 08 01; 92(2):285-299.
    View in: PubMed
    Score: 0.013
  72. Choy HK, Kokkinidis DG, Cotter R, Singh GD, Rogers RK, Waldo SW, Laird JR, Armstrong EJ. Long-term outcomes after carotid artery stenting of patients with prior neck irradiation or surgery. Cardiovasc Revasc Med. 2018 Apr - May; 19(3 Pt B):327-332.
    View in: PubMed
    Score: 0.013
  73. Kobayashi T, Glorioso TJ, Armstrong EJ, Maddox TM, Plomondon ME, Grunwald GK, Bradley SM, Tsai TT, Waldo SW, Rao SV, Banerjee S, Nallamothu BK, Bhatt DL, Rene AG, Wilensky RL, Groeneveld PW, Giri J. Comparative Outcomes After Percutaneous Coronary Intervention Among Black and White Patients Treated at US Veterans Affairs Hospitals. JAMA Cardiol. 2017 09 01; 2(9):967-975.
    View in: PubMed
    Score: 0.013
  74. Al-Bawardy RF, Waldo SW, Rosenfield K. Advances in Percutaneous Therapies for Peripheral Artery Disease: Drug-Coated Balloons. Curr Cardiol Rep. 2017 08 24; 19(10):99.
    View in: PubMed
    Score: 0.013
  75. Foley TR, Singh GD, Kokkinidis DG, Choy HK, Pham T, Amsterdam EA, Rutledge JC, Waldo SW, Armstrong EJ, Laird JR. High-Intensity Statin Therapy Is Associated With Improved Survival in Patients With Peripheral Artery Disease. J Am Heart Assoc. 2017 07 15; 6(7).
    View in: PubMed
    Score: 0.013
  76. Khaira KB, Brinza E, Singh GD, Amsterdam EA, Waldo SW, Tong K, Pandya K, Laird JR, Armstrong EJ. Long-term outcomes in patients with critical limb ischemia and heart failure with preserved or reduced ejection fraction. Vasc Med. 2017 08; 22(4):307-315.
    View in: PubMed
    Score: 0.013
  77. Strom JB, McCabe JM, Waldo SW, Pinto DS, Kennedy KF, Feldman DN, Yeh RW. Management of Patients With Cardiac Arrest Complicating Myocardial Infarction in New York Before and After Public Reporting Policy Changes. Circ Cardiovasc Interv. 2017 May; 10(5).
    View in: PubMed
    Score: 0.012
  78. Singh GD, Brinza EK, Hildebrand J, Waldo SW, Foley TR, Laird JR, Armstrong EJ. Midterm Outcomes After Infrapopliteal Interventions in Patients With Critical Limb Ischemia Based on the TASC II Classification of Below-the-Knee Arteries. J Endovasc Ther. 2017 06; 24(3):321-330.
    View in: PubMed
    Score: 0.012
  79. Singh GD, Armstrong EJ, Waldo SW, Alvandi B, Brinza E, Hildebrand J, Amsterdam EA, Humphries MD, Laird JR. Non-compressible ABIs are associated with an increased risk of major amputation and major adverse cardiovascular events in patients with critical limb ischemia. Vasc Med. 2017 06; 22(3):210-217.
    View in: PubMed
    Score: 0.012
  80. Foley TR, Cotter RP, Kokkinidis DG, Nguyen DD, Waldo SW, Armstrong EJ. Mid-term outcomes of orbital atherectomy combined with drug-coated balloon angioplasty for treatment of femoropopliteal disease. Catheter Cardiovasc Interv. 2017 May; 89(6):1078-1085.
    View in: PubMed
    Score: 0.012
  81. Armstrong EJ, Graham LA, Waldo SW, Valle JA, Maddox TM, Hawn MT. Incomplete Revascularization Is Associated With an Increased Risk for?Major Adverse Cardiovascular Events?Among Patients Undergoing Noncardiac Surgery. JACC Cardiovasc Interv. 2017 02 27; 10(4):329-338.
    View in: PubMed
    Score: 0.012
  82. Kokkinidis DG, Waldo SW, Armstrong EJ. Treatment of coronary artery in-stent restenosis. Expert Rev Cardiovasc Ther. 2017 Mar; 15(3):191-202.
    View in: PubMed
    Score: 0.012
  83. McCabe JM, Waldo SW, Kennedy KF, Yeh RW. Treatment and Outcomes of Acute Myocardial Infarction Complicated by Shock After Public Reporting Policy Changes in New York. JAMA Cardiol. 2016 09 01; 1(6):648-54.
    View in: PubMed
    Score: 0.012
  84. Wiktor DM, Waldo SW, Armstrong EJ. Coronary Stent Failure: Fracture, Compression, Recoil, and Prolapse. Interv Cardiol Clin. 2016 07; 5(3):405-414.
    View in: PubMed
    Score: 0.012
  85. Aggarwal V, Waldo SW, Armstrong EJ. Endovascular revascularization for aortoiliac atherosclerotic disease. Vasc Health Risk Manag. 2016; 12:117-27.
    View in: PubMed
    Score: 0.012
  86. Foley TR, Waldo SW, Armstrong EJ. Antithrombotic therapy in peripheral artery disease. Vasc Med. 2016 Apr; 21(2):156-69.
    View in: PubMed
    Score: 0.011
  87. Yeo KK, Armstrong EJ, Soni K, Waldo SW, Patel M, Reeves R, MacGregor JS, Low RI, Shunk KA, Mahmud E, Rogers JH. Long-term outcomes of angiographically confirmed coronary stent thrombosis: results from a multicentre California registry. EuroIntervention. 2015 Jun; 11(2):188-95.
    View in: PubMed
    Score: 0.011
  88. Abtahian F, Waldo S, Jang IK. Comparison of heparin and bivalirudin in patients undergoing percutaneous coronary intervention without use of glycoprotein IIb/IIIa inhibitors. Catheter Cardiovasc Interv. 2015 Sep; 86(3):390-6.
    View in: PubMed
    Score: 0.011
  89. Armstrong EJ, Sab S, Singh GD, Lim W, Yeo KK, Waldo SW, Patel M, Reeves R, MacGregor JS, Low RI, Shunk KA, Mahmud E, Rogers JH. Predictors and outcomes of recurrent stent thrombosis: results from a multicenter registry. JACC Cardiovasc Interv. 2014 Oct; 7(10):1105-13.
    View in: PubMed
    Score: 0.010
  90. Reeves RR, Patel M, Armstrong EJ, Sab S, Waldo SW, Yeo KK, Shunk KA, Low RI, Rogers JH, Mahmud E. Angiographic characteristics of definite stent thrombosis: role of thrombus grade, collaterals, epicardial coronary flow, and myocardial perfusion. Catheter Cardiovasc Interv. 2015 Jan 01; 85(1):13-22.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)